SpringWorks Other Liab vs Accounts Payable Analysis

SWTX Stock

USD 44.84 0.07 0.16%

SpringWorks Therapeutics financial indicator trend analysis is much more than just breaking down SpringWorks Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether SpringWorks Therapeutics is a good investment. Please check the relationship between SpringWorks Therapeutics Other Liab and its Accounts Payable accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SpringWorks Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy SpringWorks Stock please use our How to Invest in SpringWorks Therapeutics guide.

Other Liab vs Accounts Payable

Other Liab vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of SpringWorks Therapeutics Other Liab account and Accounts Payable. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between SpringWorks Therapeutics' Other Liab and Accounts Payable is 0.43. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of SpringWorks Therapeutics, assuming nothing else is changed. The correlation between historical values of SpringWorks Therapeutics' Other Liab and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of SpringWorks Therapeutics are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Other Liab i.e., SpringWorks Therapeutics' Other Liab and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.43

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Other Liab

Accounts Payable

An accounting item on the balance sheet that represents SpringWorks Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of SpringWorks Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from SpringWorks Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into SpringWorks Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SpringWorks Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy SpringWorks Stock please use our How to Invest in SpringWorks Therapeutics guide.At this time, SpringWorks Therapeutics' Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 38.08 in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 237.1 M in 2024.

	2021	2022	2023	2024 (projected)
Cost Of Revenue	490K	1.9M	422K	400.9K
Research Development	101.7M	146.1M	150.5M	158.0M

Cost Of Revenue Research Development

SpringWorks Therapeutics fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Accounts Payable	Cash	Other Assets	Short Term Investments	Inventory	Other Current Assets	Total Liab	Treasury Stock	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Preferred Stock Total Equity	Good Will	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments
Total Assets		0.91	0.8	0.53	0.82	0.43	0.7	0.84	0.12	0.19	0.94	0.69	0.64	0.31	0.65	0.28	-0.19	-0.64	-0.64	0.94	0.86	-0.68	-0.89	0.82	0.94	0.95
Other Current Liab	0.91		0.9	0.51	0.92	0.51	0.54	0.75	0.02	0.34	0.97	0.85	0.83	0.31	0.79	0.37	-0.14	-0.84	-0.84	0.77	0.98	-0.52	-0.99	0.94	0.84	0.76
Total Current Liabilities	0.8	0.9		0.41	0.8	0.83	0.42	0.81	-0.34	0.69	0.86	0.89	0.73	-0.13	0.87	0.73	0.3	-0.74	-0.74	0.64	0.86	-0.41	-0.87	0.82	0.7	0.63
Total Stockholder Equity	0.53	0.51	0.41		0.33	0.09	0.63	0.36	-0.31	0.22	0.59	0.28	0.6	0.25	0.45	0.0	-0.13	-0.6	-0.6	0.45	0.35	-0.63	-0.43	0.72	0.48	0.37
Other Liab	0.82	0.92	0.8	0.33		0.43	0.39	0.76	0.09	0.2	0.93	0.76	0.68	0.34	0.66	0.28	-0.21	-0.69	-0.69	0.71	0.9	-0.37	-0.94	0.82	0.82	0.71
Accounts Payable	0.43	0.51	0.83	0.09	0.43		0.16	0.66	-0.64	0.9	0.48	0.67	0.34	-0.65	0.68	0.98	0.76	-0.34	-0.34	0.32	0.47	-0.17	-0.46	0.37	0.34	0.33
Cash	0.7	0.54	0.42	0.63	0.39	0.16		0.46	0.09	0.02	0.62	0.31	0.42	0.31	0.33	0.0	-0.24	-0.43	-0.43	0.69	0.45	-1.0	-0.5	0.52	0.66	0.69
Other Assets	0.84	0.75	0.81	0.36	0.76	0.66	0.46		-0.2	0.38	0.83	0.63	0.52	-0.1	0.48	0.56	0.18	-0.33	-0.33	0.87	0.68	-0.45	-0.73	0.62	0.88	0.84
Short Term Investments	0.12	0.02	-0.34	-0.31	0.09	-0.64	0.09	-0.2		-0.84	-0.03	-0.17	-0.1	0.79	-0.33	-0.7	-0.85	0.08	0.08	0.19	0.15	-0.06	-0.11	-0.07	0.15	0.26
Inventory	0.19	0.34	0.69	0.22	0.2	0.9	0.02	0.38	-0.84		0.29	0.55	0.34	-0.72	0.69	0.92	0.84	-0.4	-0.4	0.02	0.28	-0.03	-0.27	0.33	0.05	0.0
Other Current Assets	0.94	0.97	0.86	0.59	0.93	0.48	0.62	0.83	-0.03	0.29		0.78	0.75	0.29	0.73	0.33	-0.15	-0.75	-0.75	0.84	0.9	-0.61	-0.94	0.91	0.91	0.82
Total Liab	0.69	0.85	0.89	0.28	0.76	0.67	0.31	0.63	-0.17	0.55	0.78		0.73	0.01	0.79	0.58	0.15	-0.74	-0.74	0.5	0.85	-0.3	-0.84	0.77	0.64	0.52
Treasury Stock	0.64	0.83	0.73	0.6	0.68	0.34	0.42	0.52	-0.1	0.34	0.75	0.73		0.31	0.59	0.25	-0.15	-0.8	-0.8	0.53	0.82	-0.4	-0.84	0.91	0.61	0.44
Intangible Assets	0.31	0.31	-0.13	0.25	0.34	-0.65	0.31	-0.1	0.79	-0.72	0.29	0.01	0.31		-0.07	-0.76	-0.98	-0.34	-0.34	0.3	0.35	-0.28	-0.36	0.37	0.34	0.3
Common Stock	0.65	0.79	0.87	0.45	0.66	0.68	0.33	0.48	-0.33	0.69	0.73	0.79	0.59	-0.07		0.6	0.25	-0.88	-0.88	0.37	0.76	-0.32	-0.74	0.78	0.43	0.4
Property Plant Equipment	0.28	0.37	0.73	0.0	0.28	0.98	0.0	0.56	-0.7	0.92	0.33	0.58	0.25	-0.76	0.6		0.85	-0.23	-0.23	0.19	0.33	-0.01	-0.32	0.24	0.19	0.19
Long Term Debt	-0.19	-0.14	0.3	-0.13	-0.21	0.76	-0.24	0.18	-0.85	0.84	-0.15	0.15	-0.15	-0.98	0.25	0.85		0.15	0.15	-0.23	-0.2	0.21	0.21	-0.19	-0.25	-0.23
Preferred Stock Total Equity	-0.64	-0.84	-0.74	-0.6	-0.69	-0.34	-0.43	-0.33	0.08	-0.4	-0.75	-0.74	-0.8	-0.34	-0.88	-0.23	0.15		1.0	-0.38	-0.82	0.41	0.81	-0.91	-0.46	-0.37
Good Will	-0.64	-0.84	-0.74	-0.6	-0.69	-0.34	-0.43	-0.33	0.08	-0.4	-0.75	-0.74	-0.8	-0.34	-0.88	-0.23	0.15	1.0		-0.38	-0.82	0.41	0.81	-0.91	-0.46	-0.37
Net Tangible Assets	0.94	0.77	0.64	0.45	0.71	0.32	0.69	0.87	0.19	0.02	0.84	0.5	0.53	0.3	0.37	0.19	-0.23	-0.38	-0.38		0.72	-0.67	-0.76	0.66	0.96	0.98
Property Plant And Equipment Net	0.86	0.98	0.86	0.35	0.9	0.47	0.45	0.68	0.15	0.28	0.9	0.85	0.82	0.35	0.76	0.33	-0.2	-0.82	-0.82	0.72		-0.43	-0.99	0.89	0.78	0.72
Net Debt	-0.68	-0.52	-0.41	-0.63	-0.37	-0.17	-1.0	-0.45	-0.06	-0.03	-0.61	-0.3	-0.4	-0.28	-0.32	-0.01	0.21	0.41	0.41	-0.67	-0.43		0.48	-0.5	-0.64	-0.67
Retained Earnings	-0.89	-0.99	-0.87	-0.43	-0.94	-0.46	-0.5	-0.73	-0.11	-0.27	-0.94	-0.84	-0.84	-0.36	-0.74	-0.32	0.21	0.81	0.81	-0.76	-0.99	0.48		-0.92	-0.83	-0.74
Non Current Assets Total	0.82	0.94	0.82	0.72	0.82	0.37	0.52	0.62	-0.07	0.33	0.91	0.77	0.91	0.37	0.78	0.24	-0.19	-0.91	-0.91	0.66	0.89	-0.5	-0.92		0.74	0.61
Non Currrent Assets Other	0.94	0.84	0.7	0.48	0.82	0.34	0.66	0.88	0.15	0.05	0.91	0.64	0.61	0.34	0.43	0.19	-0.25	-0.46	-0.46	0.96	0.78	-0.64	-0.83	0.74		0.94
Cash And Short Term Investments	0.95	0.76	0.63	0.37	0.71	0.33	0.69	0.84	0.26	0.0	0.82	0.52	0.44	0.3	0.4	0.19	-0.23	-0.37	-0.37	0.98	0.72	-0.67	-0.74	0.61	0.94

Click cells to compare fundamentals

SpringWorks Therapeutics Account Relationship Matchups

SpringWorks Therapeutics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	334.8M	576.2M	452.5M	630.2M	725.8M	762.1M
Other Current Liab	9.3M	14.9M	25.4M	39.2M	65.6M	68.8M
Total Current Liabilities	12.0M	17.6M	30.0M	51.0M	78.2M	82.1M
Total Stockholder Equity	322.1M	557.1M	422.4M	(569.9M)	626.2M	657.5M
Accounts Payable	2.7M	1.4M	3.4M	8.0M	7.4M	7.8M
Cash	327.7M	147.1M	104.0M	67.5M	176.1M	184.9M
Other Assets	1.7M	2.6M	3.3M	3.2M	3.7M	2.2M
Other Current Assets	3.7M	4.9M	9.4M	7.5M	12.7M	13.3M
Total Liab	12.8M	19.1M	30.1M	72.1M	99.6M	104.5M
Property Plant Equipment	795K	3.0M	4.2M	18.3M	16.4M	14.7M
Net Tangible Assets	322.1M	557.1M	422.4M	558.2M	641.9M	336.2M
Property Plant And Equipment Net	795K	3.0M	4.2M	18.3M	24.1M	25.3M
Net Debt	(327.7M)	(144.4M)	(102.7M)	(62.2M)	(169.0M)	(177.4M)
Retained Earnings	(73.0M)	(118.6M)	(292.5M)	(569.9M)	(895.0M)	(850.3M)
Non Current Assets Total	3.5M	62.8M	69.6M	30.5M	224.9M	236.1M
Non Currrent Assets Other	1.7M	2.6M	3.3M	3.2M	4.2M	2.5M
Cash And Short Term Investments	327.7M	508.5M	373.5M	597.0M	479.2M	368.0M
Common Stock Shares Outstanding	43.0M	43.3M	48.5M	53.3M	63.1M	49.5M
Liabilities And Stockholders Equity	334.8M	576.2M	452.5M	(497.9M)	725.8M	762.1M
Non Current Liabilities Total	789K	1.5M	129K	21.0M	21.4M	13.9M
Other Stockholder Equity	395.1M	675.6M	715.2M	761K	1.5B	1.6B
Net Invested Capital	322.1M	557.1M	422.4M	558.2M	626.2M	386.6M
Long Term Investments	976K	57.2M	62.1M	9.0M	185.3M	194.6M
Property Plant And Equipment Gross	795K	1.1M	5.2M	19.5M	26.7M	28.1M
Total Current Assets	331.4M	513.4M	382.9M	599.8M	500.9M	374.9M
Accumulated Other Comprehensive Income	(334.8M)	41K	(312K)	(767K)	1.2M	1.3M
Net Working Capital	319.4M	495.8M	352.9M	548.7M	422.7M	344.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
CRM	Salesforce
MSFT	Microsoft

When determining whether SpringWorks Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SpringWorks Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Springworks Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Springworks Therapeutics Stock:

How To Invest In SpringWorks

Details

Is SpringWorks Stock a good investment?

Details

What is SpringWorks Therapeutics' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SpringWorks Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy SpringWorks Stock please use our How to Invest in SpringWorks Therapeutics guide.

You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for SpringWorks Stock analysis

When running SpringWorks Therapeutics' price analysis, check to measure SpringWorks Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpringWorks Therapeutics is operating at the current time. Most of SpringWorks Therapeutics' value examination focuses on studying past and present price action to predict the probability of SpringWorks Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpringWorks Therapeutics' price. Additionally, you may evaluate how the addition of SpringWorks Therapeutics to your portfolios can decrease your overall portfolio volatility.

	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios

Is SpringWorks Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SpringWorks Therapeutics. If investors know SpringWorks will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SpringWorks Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(5.15)

Revenue Per Share

0.401

Return On Assets

(0.37)

Return On Equity

(0.63)

The market value of SpringWorks Therapeutics is measured differently than its book value, which is the value of SpringWorks that is recorded on the company's balance sheet. Investors also form their own opinion of SpringWorks Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is SpringWorks Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SpringWorks Therapeutics' market value can be influenced by many factors that don't directly affect SpringWorks Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between SpringWorks Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if SpringWorks Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SpringWorks Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

SpringWorks Other Liab vs Accounts Payable Analysis

Other Liab vs Accounts Payable

Other Liab vs Accounts Payable Correlation Analysis

Correlation Coefficient

Other Liab

Accounts Payable

SpringWorks Therapeutics fundamental ratios Correlations

SpringWorks Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

SpringWorks Therapeutics fundamental ratios Accounts

Also Currently Popular

Complementary Tools for SpringWorks Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Good Will	+ 1.0	Preferred Stock Total Equity
Property Plant And Equipment Net	+ 0.98	Other Current Liab
Property Plant Equipment	+ 0.98	Accounts Payable
Cash And Short Term Investments	+ 0.98	Net Tangible Assets
Other Current Assets	+ 0.97	Other Current Liab
Non Currrent Assets Other	+ 0.96	Net Tangible Assets

Net Debt	- 1.0	Cash
Retained Earnings	- 0.99	Property Plant And Equipment Net
Retained Earnings	- 0.99	Other Current Liab
Long Term Debt	- 0.98	Intangible Assets
Retained Earnings	- 0.94	Other Current Assets
Retained Earnings	- 0.94	Other Liab